Literature DB >> 10048640

A "case control" study on the rôle of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO).

J J Bonfil1, F L Dillier, P Mercier, D Reviron, B Foti, R Sambuc, J M Brodeur, C Sedarat.   

Abstract

HLA DR4 antigens have been considered as a risk factor in periodontal disease. The aim of this "case control" study was to verify and to provide fuller clarification of such data. "Cases" or patients had to be aged between 20 and 48 years. They presented at least 5 sites spread over several teeth with an attachment loss equal or greater than 6 mm, and 10 sites spread over several teeth with periodontal pockets equal to or greater than 5 mm. Verification with a WHO probe showed an individual CPITN score of 4. Moreover, subjects whose average CPITN score for the 6 sextants was less than 3 were excluded from the study. Among these "severe periodontitis" patients, a subgroup was distinguished composed of subjects aged 20-35 years who presented, in accordance with the cases by Katz and co-workers, 5 or more teeth showing pocket depths of 6 mm or more. The dental chartings of these subjects showed an attachment loss of more than 3 mm on certain teeth over an inter-exam period of 1-3 years. They all displayed obvious loss of bony support in the affected sites. This constituted the "rapidly progressive periodontitis" subgroup. The "controls" were all over 20 years of age, and it was clinically verified that they were free of periodontal disease. There were 48 "cases" and 55 "controls". HLA typing of patients and controls was performed using "sequence oligoprobe hybridization after polymerase chain reaction" in accordance with the 11th International Workshop. This method allowed the detection of DR4 alleles as well as DR4 subtypes. The ethno-geographic origin of the subjects, considered as a confounding variable, was neutralized by stratified analysis. Subtypes 0401, 0404, 0405 and 0408 tended to be more frequent (p=0.08) in the cases (Severe Periodontitis). Focusing on analysis of "rapidly progressive periodontitis" in subjects aged 20-35 years, a very significant Mantel-Haenszel chi2 was obtained (p=0.0058) which led to a Mantel-Haenszel standardized odds ratio (OR) equal to 17. The 95% confidence interval was 1.03<0.R.<180.10. In conclusion, this supports previous reports and gives further clarification: in particular subtypes 0401, 0404, 0405 and 0408 can be considered as a risk factor for "rapidly progressive periodontitis". It should be noted that these determinants have been implicated in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048640     DOI: 10.1034/j.1600-051x.1999.260203.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  31 in total

Review 1.  New insights into the functional role of the rheumatoid arthritis shared epitope.

Authors:  Denise E de Almeida; Song Ling; Joseph Holoshitz
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

2.  The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.

Authors:  H Marotte; P Farge; P Gaudin; C Alexandre; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

Review 3.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

4.  Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis.

Authors:  Ted R Mikuls; Geoffrey M Thiele; Kevin D Deane; Jeffrey B Payne; James R O'Dell; Fang Yu; Harlan Sayles; Michael H Weisman; Peter K Gregersen; Jane H Buckner; Richard M Keating; Lezlie A Derber; William H Robinson; V Michael Holers; Jill M Norris
Journal:  Arthritis Rheum       Date:  2012-11

5.  Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.

Authors:  Ted R Mikuls; Jeffrey B Payne; Fang Yu; Geoffrey M Thiele; Richard J Reynolds; Grant W Cannon; Jeffrey Markt; David McGowan; Gail S Kerr; Robert S Redman; Andreas Reimold; Garth Griffiths; Mark Beatty; Shawneen M Gonzalez; Debra A Bergman; Bartlett C Hamilton; Alan R Erickson; Jeremy Sokolove; William H Robinson; Clay Walker; Fatiha Chandad; James R O'Dell
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

Review 6.  Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis.

Authors:  Elliot D Rosenstein; Robert A Greenwald; Laura J Kushner; Gerald Weissmann
Journal:  Inflammation       Date:  2004-12       Impact factor: 4.092

Review 7.  Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions.

Authors:  Clifton O Bingham; Malini Moni
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

Review 8.  The association between rheumatoid arthritis and periodontal disease.

Authors:  Jacqueline Detert; Nicole Pischon; Gerd R Burmester; Frank Buttgereit
Journal:  Arthritis Res Ther       Date:  2010-10-22       Impact factor: 5.156

9.  Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

Authors:  Ted R Mikuls; Jeffrey B Payne; Richard A Reinhardt; Geoffrey M Thiele; Eileen Maziarz; Amy C Cannella; V Michael Holers; Kristine A Kuhn; James R O'Dell
Journal:  Int Immunopharmacol       Date:  2008-10-09       Impact factor: 4.932

10.  Association Between Serum Antibodies to Periodontal Bacteria and Rheumatoid Factor in the Third National Health and Nutrition Examination Survey.

Authors:  Charlene E Goh; Jacob Kopp; Panos N Papapanou; Jerry A Molitor; Ryan T Demmer
Journal:  Arthritis Rheumatol       Date:  2016-10       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.